State of Wisconsin Investment Board’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Buy
279,287
+97,776
+54% +$397K ﹤0.01% 1624
2025
Q4
$1.17M Buy
181,511
+35,489
+24% +$221K ﹤0.01% 1606
2025
Q3
$816K Buy
+146,022
New +$631K ﹤0.01% 1690
2025
Q1
Sell
-25,010
Closed -$89K 2248
2024
Q4
$89K Buy
+25,010
New +$115K ﹤0.01% 2214

Other funds holding AQST

State of Wisconsin Investment Board's AQST Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Aquestive Therapeutics (AQST) stake by 54% in Q1 2026, buying an estimated $397K and bringing the position to 279,287 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

State of Wisconsin Investment Board first reported a position in AQST in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.17M in Q4 2025. 180 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • State of Wisconsin Investment Board held 279,287 shares of Aquestive Therapeutics worth $1.16M as of Q1 2026.
  • State of Wisconsin Investment Board bought 97,776 Aquestive Therapeutics shares in Q1 2026, an estimated $397K.
  • Aquestive Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1624 holding.
  • State of Wisconsin Investment Board first reported a position in Aquestive Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • State of Wisconsin Investment Board's Aquestive Therapeutics position peaked at $1.17M in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.